Enko Chem, Inc. announced that it will issue 16,459,544 series C preferred shares at issue price of $4.8604 per share for the gross proceeds $79,999,967.658 in funding on July 15, 2022. The shares will be convertible in common shares at a price of $4.8604 per share. The company will receive $69,493,377 pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.77 AUD | -1.04% |
|
+1.49% | -8.62% |
May. 24 | Citi Downgrades Nufarm to Neutral From Buy; Price Target is AU$4.80 | MT |
May. 24 | Citi Downgrades Nufarm to Neutral From Buy, Price Target is AU$4.80 | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.62% | 1.22B | |
-8.87% | 3.22B | |
-30.84% | 1.86B | |
-9.72% | 1.64B | |
-25.07% | 1.6B | |
-11.18% | 1.51B | |
-4.12% | 1.09B | |
-27.82% | 953M | |
-14.37% | 884M | |
+50.91% | 868M |
- Stock Market
- Equities
- NUF Stock
- News Nufarm Limited
- Enko Chem, Inc. announced that it expects to receive $79.999968 million in funding